Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

The National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE) to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. • The program will fund P50 SPORE grants. • Research must be translational. • Must stem from research on human biology. • Must use cellular, molecular, structural, biochemical, and/or genetic experimental approaches. • Focus on organ-specific cancer or highly related group of cancers. • Goal of reaching a translational human endpoint within the project period of the grant.